American Association for Cancer Research

Table 2.

Patient characteristics and repeat tumor PET 2-[¹¹C]thymidine parameter data

Pt	Primary site	Imaged site	Age (y)	PS	Injected activity			SUV_end			AUC_{0-1 hour}			FRT
Pt	Primary site	Imaged site	Age (y)	PS						1st	2nd	1st	2nd	1st	2nd	1st	2nd
1	Cholangiocarcinoma	Liver	39	0	323	135	2.61	2.15	205	205	0.287	0.304
2	Colorectal	Liver	61	1	383	274	1.37	1.56	131	130	0.189	0.152
3	Stomach	Lung	71	1	375	272	1.05	1.10	85	84	0.390	0.372
4	Colorectal	Liver	60	1	557	534	2.27	2.00	100	110	0.204	0.193
5	Colorectal	Liver	76	1	388	265	3.70	3.43	120	120	0.372	—
6	Pancreas	Pancreas	68	0	481	373	1.45	1.23	167	158	0.204	0.193
7	Pancreas	Pancreas	53	0	413	475	1.49	1.55	247	250	0.149	0.195

Pt	Primary site	Imaged site	Age (y)	PS	Injected activity			SUV_end			AUC_{0-1 hour}			FRT
Pt	Primary site	Imaged site	Age (y)	PS						1st	2nd	1st	2nd	1st	2nd	1st	2nd
1	Cholangiocarcinoma	Liver	39	0	323	135	2.61	2.15	205	205	0.287	0.304
2	Colorectal	Liver	61	1	383	274	1.37	1.56	131	130	0.189	0.152
3	Stomach	Lung	71	1	375	272	1.05	1.10	85	84	0.390	0.372
4	Colorectal	Liver	60	1	557	534	2.27	2.00	100	110	0.204	0.193
5	Colorectal	Liver	76	1	388	265	3.70	3.43	120	120	0.372	—
6	Pancreas	Pancreas	68	0	481	373	1.45	1.23	167	158	0.204	0.193
7	Pancreas	Pancreas	53	0	413	475	1.49	1.55	247	250	0.149	0.195

NOTE: Injected activity is expressed in MBq. SUV_end in g/mL is calculated as the average value between 3,000 and 3,600 seconds. AUC_{0-1 hour} is expressed in g-h/mL. A second FRT measurement was not obtained in one patient because of an inadequate input function.

Abbreviations: Pt, patient number; PS, WHO performance status.

View Large

This Feature Is Available To Subscribers Only